Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Appointed director
|
GLYCOMIMETICS INC (GLYC)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/07/2021 |
GN
| APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia |
11/06/2018 |
GN
| Report: Developing Opportunities within Stryker, Anavex Life Sciences, Engility, Baker Hughes, a GE company, GlycoMimetics, and HCP — Future Expectations, Projections Moving into 2018 |
07/27/2018 |
GN
| Factors of Influence in 2018, Key Indicators and Opportunity within Minerals Technologies, USG, Continental Resources, Take-Two Interactive Software, Trimble, and GlycoMimetics — New Research Emphasizes Economic Growth |
05/22/2018 |
GN
| New Research Coverage Highlights Apollo Commercial Real Estate Finance, Drive Shack, GlycoMimetics, Dycom Industries, Apple Hospitality REIT, and Howard Hughes — Consolidated Revenues, Company Growth, and Expectations for 2018 |
01/26/2018 |
GN
| New Research: Key Drivers of Growth for NanoString Technologies, Oaktree Capital Group, Midstates Petroleum, GlycoMimetics, State Street, and Retail Properties of America — Factors of Influence, Major Initiatives and Sustained Production |
|
|